statistiche ricercatore

Nome	#
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations	65
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report	56
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer	48
Adding weekly carboplatin to sequential anthracycline and paclitaxel-based chemotherapy as neoadjuvant treatment for triple negative breast cancer (TNBC) patients: a propensity scorematched study	43
Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-T	37
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8)	19
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation	16
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma	16
Totale	300

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	18	0	0	0	0	0	0	4	0	1	0	5	8
2022/2023	71	5	6	7	7	8	6	1	15	4	2	4	6
2023/2024	199	7	8	16	20	25	26	36	5	12	7	14	23
2024/2025	12	10	2	0	0	0	0	0	0	0	0	0	0
Totale													300